Journal of Clinical Lipidology

Article	Citations
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction	123
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group	81
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient	69
Saturated fats and cardiovascular health: Current evidence and controversies	55
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy	49
Ketogenic diets, not for everyone	45
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)	42
Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial	42
Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment	38
Guidance for the diagnosis and treatment of hypolipidemia disorders	32
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association	31
Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: A secondary analysis of the CLEAR harmony trial	30
A mechanism-based operational definition and classification of hypercholesterolemia	28
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association	27
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice	26
HDL proteome remodeling associates with COVID-19 severity	26
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial	25
Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study	25
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials	23
Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching	23
Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction	22
Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association	22
Association between statin use and cognitive function: A systematic review of randomized clinical trials and observational studies	22
Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events	22
Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia	22

PCSK9 inhibition in clinical practice: Treatment patterns and attainment of lipid goals in a large health maintenance organization	21
Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association	21
Real-world utilization of bempedoic acid in an academic preventive cardiology practice	20
Association of high maternal triglyceride levels early and late in pregnancy with adverse outcomes: A retrospective cohort study	20
Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia	19
Small interfering ribonucleic acid for cholesterol lowering – Inclisiran	19
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia	18
Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a)	17
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19	17
Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes	16
Lipoprotein(a) and inflammation- pathophysiological links and clinical implications for cardiovascular disease	16
Hyperlipidemia and risk for preclampsia	15
Closing the gap: Identification and management of familial hypercholesterolemia in an integrated healthcare delivery system	15
Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction	15
Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States	15
Negative impact of COVID-19 pandemic on the lifestyle and management of patients with homozygous familial hypercholesterolemia	15
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial	14
Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis	14
Prevalence of severe hypertriglyceridemia and pancreatitis in familial partial lipodystrophy type 2	14
Sex differences in LDL-C response to PCSK9 inhibitors: A real world experience	14
C3 and alternative pathway components are associated with an adverse lipoprotein subclass profile: The CODAM study	13
Clinical, genetic profile and therapy evaluation of 55 children and 5 adults with sitosterolemia	13
Lower triglyceride levels are associated with better endothelial function	12
CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis	12
Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy	12
Evolocumab in patients with homozygous familial hypercholesterolemia in India	12
Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjects	12
Mustard oil and cardiovascular health: Why the controversy?	12
Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research	12
Comprehensive (apo)lipoprotein profiling in patients with genetic hypertriglyceridemia using LC-MS and NMR spectroscopy	11
Familial hypercholesterolemia in Mexico: Initial insights from the national registry	11
Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic	11
Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA)	11
Sex‐related differences in premature cardiovascular disease in familial hypercholesterolemia	11
Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysis	11
JCL roundtable: Lipids and inflammation in atherosclerosis	10
The economic impact of familial hypercholesterolemia on productivity	10
Characteristics and trends of PCSK9 inhibitor prescription fills in the United States	10
Effectiveness of medical nutrition therapy in the management of adult dyslipidemia: A systematic review and meta-analysis	10
Lipoprotein (a) is associated with poor long-term prognosis in patients aged 80 years and older with acute coronary syndrome	10
Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience	10
The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants	10
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Pre	10
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis	10
Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome	10
Reference values for the triglyceride to high-density lipoprotein ratio and its association with cardiometabolic diseases in a mixed adult population: The ELSA-Brasil study	9
Cholestasis as a dominating symptom of patients with CYP27A1 mutations: An analysis of 17 Chinese infants	9
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia	9
Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India	9
Functional profiling of LDLR variants: Important evidence for variant classification	8

The triglyceride to HDL-cholesterol ratio and chronic graft failure in renal transplantation	8
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)	8
Perimenopausal transdermal estradiol replacement reduces serum HDL cholesterol efflux capacity but improves cardiovascular risk factors	8
Prevalence, severity and management of hypertriglyceridemia-associated pancreatitis; A 7-year retrospective cohort study at Canadian quaternary care hospitals	8
Diet-derived and diet-related endogenously produced palmitic acid: Effects on metabolic regulation and cardiovascular disease risk	8
Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) – Results of a US national survey	8
High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey	8
Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study	8
Lipidomic changes of LDL after consumption of Camelina sativa oil, fatty fish and lean fish in subjects with impaired glucose metabolism—A randomized controlled trial	8
Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective	8
Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD	8
Lipoprotein(a) and coronary artery calcium in comparison with other lipid biomarkers: The multi-ethnic study of atherosclerosis	8
Impact of small dense low-density lipoprotein cholesterol on cholesterol crystals in patients with acute coronary syndrome: An optical coherence tomography study	8
Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?	8
Subjects with familial hypercholesterolemia have lower aortic valve area and higher levels of inflammatory biomarkers	8
Incident CHD and ischemic stroke associated with lipoprotein(a) by levels of Factor VIII and inflammation	7
Update on the omega-3 fatty acid trial landscape: A narrative review with implications for primary prevention	7
Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT	7
Exploring rates of PCSK9 inhibitor persistence and reasons for treatment non-persistence in an integrated specialty pharmacy model	7
The impact of dyslipidemia on early markers of endothelial and renal dysfunction in children	7
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis	7
Applying an LDL-C threshold-based approach to identify individuals with familial hypercholesterolemia	7
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia	7
Extreme elevations of low-density lipoprotein cholesterol with very low carbohydrate, high fat diets	7
Lipoprotein(a), metabolic profile and new-onset type 2 diabetes in patients with familial combined hyperlipidemia: A 9 year follow-up study	7
Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States	7
Circulating levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery disease	7
Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins	7
Ancestry-specific profiles of genetic determinants of severe hypertriglyceridemia	7
Familial hypercholesterolemia related admission for acute coronary syndrome in the United States: Incidence, predictors, and outcomes	7
Chronic kidney disease and statin eligibility	7
Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy	7
Nutrition interventions for youth with dyslipidemia: a National Lipid Association clinical perspective	6
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024	6
Corneal confocal microscopy identifies small nerve fibre damage in patients with hypertriglyceridemia	6
Remnant cholesterol and risk of myocardial infarction in patients with coronary artery disease undergoing revascularization	6
Familial hypobetalipoproteinemia caused by homozygous loss-of-function mutations in PCSK9: A case report	6
Adherence to lipid monitoring and its impact on treatment intensification of LDL-C lowering therapies at an urban academic medical center	6
Atorvastatin-associated rhabdomyolysis in a patient with a novel variant of the SLCO1B1 gene: A case report	6
Concerns regarding NMR lipoprotein analyses performed on the Nightingale heath platform – Focus on LDL subclasses	6
GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis	6
The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway	6
Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease	6
Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers	6
Impact of a virtual lipid clinic on lipid-lowering therapy, LDL cholesterol levels, and outcomes in patients with acute coronary syndrome	6
Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study	6
Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm	6
Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia	6
Utility of metabolic syndrome as a risk enhancing factor in decision of statin use	6
Atherosclerotic cardiovascular disease in hyperalphalipoproteinemia due to LIPG variants	6
Association between lipoprotein(a) and long-term outcomes after percutaneous coronary intervention for lesions with in-stent restenosis	6
Coronary computed tomography angiography evaluation of plaque morphology and its relationship to HDL and total cholesterol to HDL ratio	5
Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD)	5
Recommended and observed statin use among U.S. adults – National Health and Nutrition Examination Survey, 2011-2018	5
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study	5
Identifying reference values for serum lipids in Chinese children and adolescents aged 6–17 years old: A national multicenter study	5
Measurement of apolipoprotein B levels helps in the identification of patients at risk for hypertriglyceridemic pancreatitis	5
Reduction of cardiovascular events with the use of lipid-lowering medication in patients with familial hypercholesterolemia or severe primary hypercholesterolemia: A systematic review	5
Non-alcoholic fatty liver disease in patients with chylomicronemia syndromes	5
Involvement of a homozygous exon 6 deletion of LMF1 gene in intermittent severe hypertriglyceridemia	5
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India	5
Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion	5
Lipoprotein subtypes after testosterone therapy in transmasculine adolescents	5
The changing pattern of statin use in people with dementia: A population-based study	5
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemia	5
Prevalence of lipoprotein(a) measurement in patients with or at risk of cardiovascular disease	5
Novel PPARG mutation in multiple family members with chylomicronemia	4
Forty year follow-up of three patients with complete absence of apolipoprotein B-containing lipoproteins	4
Impact of small dense low-density lipoprotein cholesterol and triglyceride-rich lipoproteins on plaque rupture with ST-segment elevation myocardial infarction	4
Severe hypertriglyceridemia secondary to splice-site and missense variants in LMF1 in three patients from Ecuador	4
Effect of evolocumab on fasting and post fat load lipids and lipoproteins in familial dysbetalipoproteinemia	4
Circulating GPIHBP1 levels and microvascular complications in patients with type 2 diabetes: A cross-sectional study	4
Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction	4
Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice	4
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI	4
Monocyte phenotyping and management of lipoprotein X syndrome	4
Circulating high density lipoprotein distinguishes alcoholic hepatitis from heavy drinkers and predicts 90-day outcome	4
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system	4
Effectiveness of the triglyceride-glucose index and triglyceride-glucose-related indices in predicting cardiovascular disease in middle-aged and older adults: A prospective cohort study	4
Contribution of hypertriglyceridemia to ischemic cardiovascular disease in Korean women: A nationwide population-based study	4

Cardiometabolic risk factors in siblings from a statewide screening program	4
Free fatty acids and heart failure in the Multi-Ethnic Study of Atherosclerosis (MESA)	4
Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients	4
Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19	4
LDL receptor and pathogen processes: Functions beyond normal lipids	4
The Relationship of Alcohol Consumption and HDL Metabolism in the Multiethnic Dallas Heart Study	4
A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease	4
Impact of telehealth on the current and future practice of lipidology: a scoping review	4
Under-reporting and under-representation of non-Hispanic Black subjects in lipid-lowering atherosclerotic cardiovascular disease outcomes trials: A systematic review	4
Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome	4
Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care	4
Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trials	4
†Safety and Efficacy of Bempedoic Acid in Patients with Renal Impairment	4
Homozygous familial hypercholesterolemia in China: Genetic and clinical characteristics from a real-world, multi-center, cohort study	4
Admission LDL-cholesterol, statin pretreatment and early outcomes in acute ischemic stroke	4
Recurrence for patients with first episode of hypertriglyceridemia-induced acute pancreatitis: A prospective cohort study	4
First clinical experiences with inclisiran in a real-world setting	4
Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease	4
Prevention: The past, present, and future of medicine and society	4
Evaluating the role of statins in prevention of preeclampsia: deeper insights into maternal cardiometabolic changes	4
A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans	3
Variability of longitudinal triglyceride phenotype in patients heterozygous for pathogenic APOA5 variants	3
Ethyl EPA and ethyl DHA cause similar and differential changes in plasma lipid concentrations and lipid metabolism in subjects with low-grade chronic inflammation	3
Cerebrotendinous xanthomatosis, sitosterolemia, Smith-Lemli-Opitz syndrome and the seminal contributions of Gerald Salen, MD (1935–2020)	3
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia	3
The prognostic value of high-density lipoprotein cholesterol in patients with decompensated cirrhosis: a propensity score matching analysis	3
The association between triglyceride-rich lipoproteins, circulating leukocytes, and low-grade inflammation: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)	3
Proprotein convertase subtilisin/kexin type 9 inhibitor utilization and low-density lipoprotein-cholesterol control in familial hypercholesterolemia	3
Normal plasma apoB48 despite the virtual absence of apoB100 in a compound heterozygote with novel mutations in the MTTP gene	3
Hypercholesterolemia exacerbated by a ketogenic diet	3
In vitro fertilization and hypertriglyceridemic pancreatitis: Case report	3
Guideline based eligibility for primary prevention statin therapy – Insights from the North India ST-elevation myocardial infarction registry (NORIN-STEMI)	3
Genetic basis and hematologic manifestations of sitosterolemia in a group of Turkish patients	3
Correlation between early changes of serum lipids and clinical severity in patients with wasp stings	3
Association of demographic and health characteristics with circulating oxysterol concentrations	3
A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels	3
A systematic review of cost-effectiveness analysis of different screening strategies for familial hypercholesterolemia	3
Quantifying the contribution of lipoprotein(a) to all apoB containing particles	3
Rhabdomyolysis due to rosuvastatin in a patient with ROHHAD syndrome	3
JCL Roundtable: Global Think Tank on Lipoprotein(a)	3
Sex differences in the associations of HDL particle concentration and cholesterol efflux capacity with incident coronary artery disease in type 1 diabetes: The RETRO HDLc cohort study	3
JCL Roundtable: Lipidology and Women's Health	3
Longitudinal changes in HDL-cholesterol concentration are associated with different risk factors in primiparous and nulliparous young women: The NHLBI Growth and Health Study (NGHS)	3
Counseling couples at risk of having a child with homozygous familial hypercholesterolemia – Clinical experience and recommendations	3
Family history of diabetes determines the association of HOMA-IR with fasting and postprandial triglycerides in individuals with normal glucose tolerance	3
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients	3
A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients	3
Plasma lipoprotein subclass variation in middle-aged and older adults: Sex-stratified distributions and associations with health status and cardiometabolic risk factors	3
JCL Roundtable. Making prevention a priority	3
Statins, lipids and dementia?	3
The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia	3
Plasma HDL pattern, cholesterol efflux and cholesterol loading capacity of serum in carriers of a novel missense variant (Gly176Trp) of endothelial lipase	3
The independent associations of anti-Müllerian hormone and estradiol levels over the menopause transition with lipids/lipoproteins: The Study of Women's health Across the Nation	3
Monogenic and polygenic causes of low and extremely low LDL-C levels in patients referred to specialty lipid clinics: Genetics of low LDL-C	3
Composition and distribution of lipoproteins after evolocumab in familial dysbetalipoproteinemia: A randomized controlled trial	2
Impaired cholesterol efflux capacity in patients with Helicobacter pylori infection and its relation with inflammation	2
High-density lipoprotein infusion therapy: A review	2
Translating Evidence-based Approaches into optimal Care for individuals at High-risk of ASCVD: Pilot testing of case-based e-learning modules and design of the TEACH-ASCVD study	2
Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection	2
Universal lipid screening in adolescents to identify familial hypercholesterolemia in a large healthcare system	2
The Effect of Estrogen and Testosterone on Cholesterol Crystallization	2
Misdiagnosis of sitosterolemia in a patient as Evans syndrome and familial hypercholesterolemia	2
Dietary recommendations for dysbetalipoproteinemia: A need for better evidence	2
Obicetrapib Lowers LDL-C in Patients Taking High Intensity Statins - Results from the ROSE Clinical Trial	2
How low should one go in reducing carbohydrate?	2
Clinical reasoning and prevention of cardiovascular disease	2
Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndrome	2
Increases in erythrocyte DHA are not associated with increases in LDL-cholesterol: Cooper center longitudinal study	2
Spontaneous splenic rupture as the first clinical manifestation of Niemann-Pick disease type B: A case report and review of the literature	2
One-year statin persistence and adherence in adults with HIV in the United States	2
Association between remnant cholesterol and incident atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation	2
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study	2
Direct LDL-C estimation in preschoolers: Practicable first step for FH screening	2
Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations	2
Coronary artery calcium scoring in patients with statin associated muscle symptoms: Prescribing statins for those most likely to benefit	2
Impact of variants of uncertain significance of LDL receptor on phenotypes of familial hypercholesterolemia	2
ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia	2
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset	2
Treatment of cerebrotendinous xanthomatosis in pregnancy: Patient and physician perspectives	2
Sex differences in the perception of cardiovascular risk in familial hypercholesterolemia	2
Statin therapy for primary prevention in women: What is the role for coronary artery calcium?	2
Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia	2
Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten	2
Serum 25-hydroxycholesterol levels are increased in patients with coronavirus disease 2019	2
A stepwise approach to prescribing novel lipid-lowering medications	2
Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia	2
Clinical trials to improve outcomes in patients with elevated Lp(a) undergoing PCI: The time has arrived	2
Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosis	2
A novel homozygous nonsense variant of LMF1 in pregnancy-induced hypertriglyceridemia with acute pancreatitis	2
Cardiovascular Mortality and Hospitalization Risk with LDL by CKD Stage in African-American and White US Veterans	2
Simulation of lipid-lowering therapy (LLT) intensification in very high-risk patients with atherosclerotic cardiovascular disease	2
Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction model	2
Impact of triglyceride-rich lipoproteins on early in-stent neoatherosclerosis formation in patients undergoing statin treatment	2
Early use of PCSK9 inhibitor therapy after heart transplantation from a hepatitis C virus positive donor	2
Cholesterol screening and intervention in youth - It's time to move on	1